A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt®) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study

Author： Phuphanich Surasak   Maria Bernard   Braeckman Rene   Chamberlain Marc  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.81, Iss.2, 2007-01, pp. : 201-208

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Final results of a phase I and pharmacokinetic study of γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors

By Johansen Mary   Zukowski Thomas   Hoff Paulo   Newman Robert   Ni Dan   Hutto Toni   Abbruzzeese James   Berghorn Elmer   Hausheer Frederick   Madden Timothy  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 370-376

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Pharmacokinetic Study of Nivolumab in Korean Patients with Advanced Solid Tumors

By  

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 155-e17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors

By Nemunaitis John   Mita Alain   Stephenson Joe   Mita Monica   Sarantopoulos John   Padmanabhan-Iyer Swami   Nanda Nisha   Gleich Lyon   Benichou Annie-Claude   Craig Adam  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 35-41

Springer Publishing Company

Access to resources Recommend Favorite

A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors

By Okamoto Wataru   Yoshino Takayuki   Takahashi Toshiaki   Okamoto Isamu   Ueda Shinya   Tsuya Asuka   Boku Narikazu   Nishio Kazuto   Fukuoka Masahiro   Yamamoto Nobuyuki   Nakagawa Kazuhiko  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 5, 2013-11 ,pp. : 1063-1071

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors

By Gordon Michael   Ilaria Robert   Alwis Dinesh   Mendelson David   McKane Scott   Wagner Margaret   Look Katherine   LoRusso Patricia  

Cancer Chemotherapy and Pharmacology, Vol. 71, Iss. 1, 2013-01 ,pp. : 21-27

Springer Publishing Company

Access to resources Recommend Favorite